´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10±³À°ÀÏÀÚ : 2019-05-10
±³À°Àå¼Ò : °æÁÖ È¹éÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071
À̸ÞÀÏ :
diabetes@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ-ȸ¿ø 130,000¿ø/ºñȸ¿ø 200,000¿ø »çÀüµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 70,000¿ø/ºñȸ¿ø 90,000¿ø ÇöÀåµî·Ï: Àü¹®ÀÇ-ȸ¿ø 200,000¿ø/ºñȸ¿ø 250,000¿ø ÇöÀåµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 90,000¿ø/ºñȸ¿ø 110,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:00~09:25 Overview: understanding the relationship between ¥â Cell dynamics and diabetes °½Å¾Ö(¿¬¼¼ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:25~09:50 GLP1 increases b cell regeneration by promoting a to b treansdifferentiation ÀüÈñ¼÷(°¡ÃµÀÇ´ë ¾Ï´ç´¢¿¬±¸¿ø)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:50~10:15 Dynamic pathology of islet endocrine cells in diabetes ¿ø±ÔÀå(¿µ³²ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 10:15~10:40 SREBP1c-PAX4 Axis in ¥â cell compensation ±èÀç¹ü(¼¿ï´ë »ý¸í°úÇкÎ)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1,2 11:30~12:10 Bring the spotlight onto a niche in diabetes research ±èÀÎÁÖ(ºÎ»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room5 12:30~13:10 Managing diabetes in elderly: go easy and individualizes ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:10~14:35 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of cardiologist Á¶Áø¸¸(°æÈñÀÇ´ë ½ÉÀå³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:35~15:00 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of endocrinologist ¼¼ºÈ¯(µ¿¾ÆÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:00~15:25 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - pro ¹Úö¿µ(¼º±Õ°üÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:25~15:50 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - cons ¹®¹Î°æ(¼¿ïÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:10~16:35 Urinary EV miRNA in the prediction of DKD progression ÀÌ´ëÈ£(°¡ÃµÀÇ´ë ³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:35~17:00 RNA sequence tramscriptome in DKD ¹Ú¹Ì¿µ(ºÎ»ê´ë ÀÇ»ý¸í¿¬±¸¿ø)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:00~17:25 Role of ACE2 in diabetic kidney disease ¹èÀºÈñ(Àü³²ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:25~17:50 Basic research in degenerative eye disease in diabetes ¹ÚÅ°ü(¼øõÇâÀÇ´ë ¾È°ú)